Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Imaging of Patients With Lower Grade Glioma Using Hyperpolarized 13C Pyruvate

NCT04540107 is registered in ClinicalTrials.gov with Susan Chang as lead sponsor.

NCT NCT04540107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04540107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Imaging of Patients With Lower Grade Glioma Using Hyperpolarized 13C Pyruvate
Lead sponsor
Susan Chang
Phase
Phase 1
Overall status
Recruiting
Start date
January 11, 2017
Completion date
January 31, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent who grade iii glioma, recurrent world health organization (who) grade ii glioma, who grade ii glioma, who grade iii glioma